Erina Takai
Overview
Explore the profile of Erina Takai including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
28
Citations
687
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Horie M, Tanaka H, Suzuki M, Sato Y, Takata S, Takai E, et al.
Cancer Sci
. 2023 Feb;
114(6):2596-2608.
PMID: 36840413
Neuroendocrine carcinoma (NEC) is a highly aggressive subtype of the neuroendocrine tumor with an extremely poor prognosis. We have previously conducted a comprehensive genomic analysis of over 100 cases of...
2.
Tanaka J, Nakagawa T, Harada K, Morizane C, Tanaka H, Shiba S, et al.
Sci Rep
. 2023 Feb;
13(1):3039.
PMID: 36810451
A highly sensitive and highly multiplexed quantification technique for nucleic acids is necessary to predict and evaluate cancer treatment by liquid biopsy. Digital PCR (dPCR) is a highly sensitive quantification...
3.
Yachida S, Totoki Y, Noe M, Nakatani Y, Horie M, Kawasaki K, et al.
Cancer Discov
. 2021 Dec;
12(3):692-711.
PMID: 34880079
Significance: GIS-NECs are genetically distinct from GIS-NETs. GIS-NECs arising in different organs show similar histopathologic features and share some genomic features, but considerable differences exist between Panc-NECs and Nonpanc-NECs. In...
4.
Tanaka H, Suzuki M, Takemoto N, Fukusumi T, Eguchi H, Takai E, et al.
Int J Cancer
. 2021 Sep;
150(1):174-186.
PMID: 34486724
A biomarker that is useful for the detection of human papillomavirus (HPV)-related oropharyngeal cancer (OPC) and cancer of unknown primary (CUP) is indispensable. We evaluated the diagnostic performance of HPV...
5.
Takai E, Omata W, Totoki Y, Nakamura H, Shiba S, Takahashi A, et al.
Cancer Sci
. 2021 Sep;
112(11):4748-4757.
PMID: 34477284
Assessment of treatment efficacy of immune checkpoint inhibitors in melanoma patients is difficult as the response to these therapies varies among patients or lesions. The clonal evolution of cancer during...
6.
Suzuki M, Saito-Adachi M, Arai Y, Fujiwara Y, Takai E, Shibata S, et al.
Cancer Res
. 2020 Dec;
81(2):489-500.
PMID: 33293429
The transcription factor E74-like factor 3 (ELF3) is inactivated in a range of cancers, including biliary tract cancer (BTC). Here, we investigated the tumor-suppressive role of ELF3 in bile duct...
7.
Tanaka H, Takemoto N, Horie M, Takai E, Fukusumi T, Suzuki M, et al.
Int J Cancer
. 2020 Sep;
148(4):995-1005.
PMID: 32895945
Positron emission tomography and computed tomography (PET-CT) is widely used to assess the response to radiotherapy. However, the ability of PET-CT to predict treatment failure in human papillomavirus (HPV)-related squamous...
8.
Takai E, Nakamura H, Chiku S, Kubo E, Ohmoto A, Totoki Y, et al.
Ann Surg
. 2020 Aug;
275(4):e652-e658.
PMID: 32826389
Objective: The primary objective of this study was to identify novel genes that predispose people in the Japanese population to FPC. Summary Of Background Data: Familial history of pancreatic cancer...
9.
Takai E, Maeda D, Li Z, Kudo-Asabe Y, Totoki Y, Nakamura H, et al.
Sci Rep
. 2020 Feb;
10(1):2120.
PMID: 32034265
Recent genomic studies on cancer tissues obtained during rapid autopsy have provided insights into the clonal evolution and heterogeneity of cancer. However, post-mortem blood has not been subjected to genetic...
10.
Lee J, Rhee T, Pietrasz D, Bachet J, Laurent-Puig P, Kong S, et al.
Sci Rep
. 2019 Nov;
9(1):16971.
PMID: 31740696
Circulating tumor DNA (ctDNA) is a promising prognostic biomarker in various cancers. Due to the high recurrence rate of resectable pancreatic ductal adenocarcinoma (PDAC), effective strategies for prognostic stratification are...